Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
Oliver H. Miller, Jacqueline Moran, Benjamin J. Hall
Neuropharmacology (2015) Vol. 100, pp. 17-26
Closed Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 775
Dopamine System Dysregulation in Major Depressive Disorders
Pauline Belujon, Anthony A. Grace
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 12, pp. 1036-1046
Open Access | Times Cited: 602
How do antidepressants work? New perspectives for refining future treatment approaches
Catherine J. Harmer, Ronald S. Duman, Philip J. Cowen
The Lancet Psychiatry (2017) Vol. 4, Iss. 5, pp. 409-418
Open Access | Times Cited: 501
GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
Danielle M. Gerhard, Santosh Pothula, Rong-Jian Liu, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 3, pp. 1336-1349
Open Access | Times Cited: 268
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Lulu Cui, Shu Li, Siman Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 234
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Allison C. Nugent, Elizabeth D. Ballard, Todd D. Gould, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 7, pp. 1040-1052
Open Access | Times Cited: 218
Ketamine: NMDA Receptors and Beyond
Charles F. Zorumski, Yukitoshi Izumi, Steven Mennerick
Journal of Neuroscience (2016) Vol. 36, Iss. 44, pp. 11158-11164
Open Access | Times Cited: 198
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Pharmacology & Therapeutics (2018) Vol. 190, pp. 148-158
Open Access | Times Cited: 198
Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
Allie J. Widman, Lori L. McMahon
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 13
Open Access | Times Cited: 181
Modality-specific tracking of attention and sensory statistics in the human electrophysiological spectral exponent
Leonhard Waschke, Thomas Donoghue, Lorenz Fiedler, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 174
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 166
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 155
The antidepressant actions of ketamine and its enantiomers
Jenessa N. Johnston, Ioline D. Henter, Carlos A. Zarate
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108431-108431
Open Access | Times Cited: 72
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 56
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 48
Periodic and aperiodic changes to cortical EEG in response to pharmacological manipulation
Sofia V. Salvatore, Peter Lambert, Ann Benz, et al.
Journal of Neurophysiology (2024) Vol. 131, Iss. 3, pp. 529-540
Open Access | Times Cited: 20
Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
Ashley E. Lepack, Eunyoung Bang, Boyoung Lee, et al.
Neuropharmacology (2016) Vol. 111, pp. 242-252
Open Access | Times Cited: 162
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 144
New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs
Zuleide Maria Ignácio, Gislaine Z. Réus, Camila O. Arent, et al.
British Journal of Clinical Pharmacology (2015) Vol. 82, Iss. 5, pp. 1280-1290
Open Access | Times Cited: 142
GABA interneurons mediate the rapid antidepressant-like effects of scopolamine
Eric S. Wohleb, Min Wu, Danielle M. Gerhard, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 7, pp. 2482-2494
Open Access | Times Cited: 138
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling
Laura Cavalleri, Emilio Merlo Pich, Mark J. Millan, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 4, pp. 812-823
Open Access | Times Cited: 130
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Ronald S. Duman, Ryota Shinohara, Manoela V. Fogaça, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 12, pp. 1816-1832
Open Access | Times Cited: 129
( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions
Panos Zanos, Jaclyn N. Highland, Brent W. Stewart, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 13, pp. 6441-6450
Open Access | Times Cited: 128
A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery
Yunfeng Li
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107494-107494
Closed Access | Times Cited: 123
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Todd D. Gould, Carlos A. Zarate, Scott M. Thompson
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 213-236
Open Access | Times Cited: 117
Page 1 - Next Page

Scroll to top